IP Library › Granted Patent US 8,207,245
Granted Patent B2
US 8,207,245 · App. 11/663,870 · Granted Jun 26, 2012

Gels

Assignee: Aortech International plc
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,207,245
App. No.
11/663,870
Granted
Jun 26, 2012
Kind
B2
Abstract

The present invention relates to silicon-containing biostable gels and processes for their preparation. The gels possess properties which make them useful in the manufacture and repair of biomaterials and medical devices, articles or implants, in particular the manufacture of soft tissue implants such as breast implants and the repair of orthopaedic joints such as spinal discs.

Claims (19)

1. A chemical gel comprising at least one silicon-containing biostable polymer having monomers with an average functionality in the range of from 2.05 to 3.5 in which the biostable polymer is a polyurethane or polyurethane urea which is a reaction product of:

(a) at least one silicon-containing polyol or polyamine having 2 or more functional groups in which the silicon-containing polyol or polyamine is a compound of formula (II)

in which R 1 is selected from C 1-6 alkylene optionally substituted with OH or NR′R″ in which R′ and R″ are independently selected from H, CO 2 H and C 1-6 alkyl;

R 9 is C 1-4 alkyl;

R 10 is optionally substituted C 1-4 alkyl or

in which R 1 and R 9 are as defined above;

x is 5 to 30;

y is 1 to 10; and

n is 1 to 10;

(b) a polyisocyanate; and

(c) at least one non-silicon containing compound selected from a polycarbonate or a C 1-6 alkane having 1 or more functional groups selected from OH, NR′R″ in which R′ and R″ are the same or different and selected from H, CO 2 H and C 1-6 alkyl; wherein the gel has an NCO/OH or NH 2 ratio less than 1.

2. A gel according to claim 1 in which the average functionality is from 2.1 to 3.25.

3. A gel according to claim 1 in which the compound of formula (II) is as follows:

in which n is as defined in claim 1 , wherein the molecular weight of the compound of formula (IIa) or (IIb) is from 1000-5000.

4. A gel according to claim 1 in which the polyisocyanate (b) is polymeric 4,4′-diphenylmethane diisocyanate (MDI), methylene biscyclohexyl diisocyanate (H 12 MDI), p-phenylene diisocyanate (p-PDI), trans-cyclohexane-1,4-diisocyanate (CHDI), 1,6-diisocyanatohexane (DICH), 1,5-diisocyanatonaphthalene (NDI), para-tetramethylxylenediisocyanate (p-TMXDI), meta-tetramethylxylene diisocyanate (m-TMXDI), 2,4-toluene diisocyanate (2,4-TDI) isomers or mixtures thereof or isophorone diisocyanate (IPDI).

5. A gel according to claim 1 in which the polycarbonate is a poly(alkylene carbonate); a polycarbonate prepared by reacting alkylene carbonate with alkanediol or a silicon based polycarbonate prepared by reacting alkylene carbonate with 1,3-bis(4-hydroxybutyl)-1,1,3,3-tetramethyldisiloxane (BHTD) and/or alkanediol.

6. A gel according to claim 1 in which the C 1-6 alkane having 1 or more functional groups is methane diol, butane diol or hexane diol.

7. A gel according to claim 1 in which the NCO/OH or NH 2 ratio is from 0.4 to 0.7.

8. A gel according to claim 1 having less than 35% extractables.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2011
From: AORTECH BIOMATERIALS PTY LTD
To: AORTECH INTERNATIONAL PLC
Reel/Frame 026449/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2008
From: PADSALGIKAR, AJAY; NHAN, TRANG THANH; VENKATARAMANI, SRIRAM; MEHRABI, MANSOUR; BOWN, MARK
To: AORTECH BIOMATERIALS PTY LTD
Reel/Frame 021473/0044 →
Priority Claims (1)
AU 2004905628 · Sep 29, 2004 · national
Continuity (1)
Related Publication 20080293844A1 · Nov 27, 2008